KV PHARMACEUTICAL CO
- AMAG Pharmaceuticals acquires Lumara Health's Maternal Health Business Clinical Trials Today [CenterWatch]
- AMAG Pharma Acquiring Stem-Cell Bank For $700 Million Investor's Business Daily Technology News
- GTCR Announces Sale of Cord Blood Registry to AMAG Pharmaceuticals Business Wire Professional Services News
- $600M acquisition pays off for Waltham drug company The Boston Business Journal - Local News - Boston, MA
- Amag, Takeda end partnership to market anemia drug in Canada and Europe The Boston Business Journal - Local News - Boston, MA
- AMAG Pharmaceuticals acquires Lumara Health's Maternal Health Business Pharmaceutical Business Review
- Lumara sells maternal-health business to Amag Pharma in up to $1B deal Biotechnology Industry Organization BIO SmartBrief
- AMAG to buy Lumara's women health business for $675m Pharmaceutical Business Review
- Troubled AMAG snaps up fresh-from-bankruptcy Lumara in $1.25B deal Fierce Pharma
- Lumara Health to sell assets to AMAG, Perrigo for $757 million Fidelity - Merger and Acquision News
Community Payment Ratings
Cortera is much more than an awesome business directory! It's an active community where real business people share the real deal on real businesses.
It's invaluable intel that's now available for FREE.
- Get the inside scoop with ratings and reviews on KV PHARMACEUTICAL CO
- Rate KV PHARMACEUTICAL CO on their payment behavior
- Ask your network about KV PHARMACEUTICAL CO with Cortera Circles
The information contained in this company profile is compiled from third party sources, including but not limited to public records, user submissions, and other commercially available data sources. These sources may not be accurate, complete, or up-to-date. Cortera makes no representations or warranties regarding, and assumes no responsibility for, the accuracy, completeness, or currency of the information contained herein.